Allergy Hay Fever Reliever
- Product NDC
- 57955-9002
- Requested package NDC
- 57955-9002-2
- 11-digit product format
- 579559002
- Labeler code
- 57955
- Product ID
- 57955-9002_5cf2899a-f527-4f6a-96a9-2391e3590a2e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Allium cepa, Ambrosia artemisiaefolia, Arsenicum album, Arum triphyllum, Arundo mauritanica, Euphrasia officinalis, Naphthalinum, Natrum muriaticum, Sabadilla, Wyethia helenioides
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- King Bio Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2022-04-22
- Marketing end
- 0000-00-00
- Substance
- AMBROSIA ARTEMISIIFOLIA WHOLE; ARISAEMA TRIPHYLLUM ROOT; ARSENIC TRIOXIDE; ARUNDO PLINIANA ROOT; EUPHRASIA STRICTA; NAPHTHALENE; ONION; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; WYETHIA HELENIOIDES ROOT
- Active strength
- 10 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 57955-9002 | 57955-9002-2 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 57955-9002 | 57955-9002-2 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 57955-9002 | 57955-9002-2 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 57955-9002-2 | 57955900202 | 59 mL in 1 BOTTLE, SPRAY (57955-9002-2) | 59 ml | 2022-04-22 | 0000-00-00 | No | No | Current |